At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
ON-DEMAND WEBINARS
Given the essential role of sleep in overall quality of life and its link to various chronic conditions, accurately measuring sleep is crucial for developing patient-centric therapies and enhancing public health.
This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
Explore key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![woman using tablet in home ps]( "Global Pharma Enables Remote Sample Collection With eCOA Solution")
Global Pharma Enables Remote Sample Collection With eCOA SolutionUnearth how a worldwide pharmaceutical company was able to facilitate the remote collection of stool specimens from patients at their residences as needed for research on infectious diseases.
-
![GettyImages-1938555153 tablet, lab]( "Accelerating Study Startups: Drive Efficiency From Protocol To Go-Live")
Accelerating Study Startups: Drive Efficiency From Protocol To Go-LiveSpeed up trial launches and maintain predictable timelines by leveraging a modern, integrated approach to eCOA setup that reduces complexity.
-
![GettyImages-1457289257 patient]( "Harnessing The Power Of eCOA Technology")
Harnessing The Power Of eCOA TechnologyGet an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.
-
![GettyImages-1398569507 regulatory]( "5 Ways To Get Ready For IRT Regulatory Inspections")
5 Ways To Get Ready For IRT Regulatory InspectionsPreparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
![GettyImages-1127397327-team-planning-meeting-boardroom-partnership]( "How Data Collection Is Enabling CROs To Expand Service Offerings")
How Data Collection Is Enabling CROs To Expand Service OfferingsExplore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.
-
![GettyImages-1327568875 data analytics]( "Harnessing The Power of Real-World Data In Clinical Trial Planning")
Harnessing The Power of Real-World Data In Clinical Trial PlanningAs the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.
-
![partnership, merger, alliance, teamwork, integration-GettyImages-1364158576]( "What The Suvoda-Greenphire Merger Means For Clinical Trials")
What The Suvoda-Greenphire Merger Means For Clinical TrialsSimplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.
-
![GettyImages-2117176337-diversity]( "Analyzing The FDA's Approach To Diversity In Clinical Trials")
Analyzing The FDA's Approach To Diversity In Clinical TrialsLearn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
![Business Globe Magnifier]( "Calling All Assessment Authors: Do You Want To Share Your COA With Sponsors Across The Globe?")
Calling All Assessment Authors: Do You Want To Share Your COA With Sponsors Across The Globe?Explore how eCOAs will become an effective way to capture data remotely throughout the trial as sponsors shift to decentralized clinical trials.
-
![GettyImages-1197856275 patient recruitment, enrollment, DCT]( "Enhancing The Patient Journey In Clinical Trials")
Enhancing The Patient Journey In Clinical TrialsUtilize supportive data to overcome the challenges of implementing a patient-focused approach to clinical trials and enhance your trial outcomes, advancing research and improving the patient journey.
FROM THE EDITOR
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
- Synthetic Control Arms: When Data Stands In For Patients
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i